“Design and Molecular Simulation of a Rituximab-Methimazole Hybrid Compound for Selective Thyroid-Stimulating Hormone Receptor Inhibition in Graves’ Disease”. SciELO Preprints, julho 22, 2025. Acesso em maio 14, 2026. https://preprints.scielo.org/index.php/scielo/preprint/view/12615.